Potent and Subtype-Selective Dopamine D


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
24 06 2021
Historique:
pubmed: 11 6 2021
medline: 26 8 2021
entrez: 10 6 2021
Statut: ppublish

Résumé

Using a previously unexplored, efficient, and versatile multicomponent method, we herein report the rapid generation of novel potent and subtype-selective DRD

Identifiants

pubmed: 34110150
doi: 10.1021/acs.jmedchem.1c00704
pmc: PMC8552448
doi:

Substances chimiques

Piperazines 0
Receptors, Dopamine D2 0
beta-Arrestins 0
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8710-8726

Références

J Med Chem. 2019 Jan 10;62(1):371-377
pubmed: 29890071
Curr Top Med Chem. 2008;8(12):1068-88
pubmed: 18691133
Pain. 2014 Sep;155(9):1829-1835
pubmed: 24954166
Angew Chem Int Ed Engl. 2000 Sep 15;39(18):3168-3210
pubmed: 11028061
J Med Chem. 2006 Jan 26;49(2):534-53
pubmed: 16420040
J Org Chem. 2018 Feb 2;83(3):1441-1447
pubmed: 29327924
Nat Commun. 2020 Feb 26;11(1):1074
pubmed: 32103023
Nature. 2016 Sep 8;537(7619):185-190
pubmed: 27533032
J Med Chem. 2017 Apr 13;60(7):2890-2907
pubmed: 28300398
J Med Chem. 2020 Mar 12;63(5):1779-1797
pubmed: 31499001
Front Synaptic Neurosci. 2018 Feb 21;10:2
pubmed: 29515433
Front Pharmacol. 2014 Nov 28;5:255
pubmed: 25506327
Chem Rev. 2012 Jun 13;112(6):3083-135
pubmed: 22435608
J Am Chem Soc. 2010 Aug 25;132(33):11443-5
pubmed: 20669948
Curr Opin Chem Biol. 2020 Jun;56:98-110
pubmed: 32446179
Elife. 2019 Nov 21;8:
pubmed: 31750832
ACS Comb Sci. 2018 Apr 9;20(4):192-196
pubmed: 29457887
Trends Pharmacol Sci. 2011 Sep;32(9):521-33
pubmed: 21680031
Bioorg Med Chem. 2017 Oct 15;25(20):5613-5628
pubmed: 28870802
Nature. 2020 Aug;584(7819):125-129
pubmed: 32528175
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18488-93
pubmed: 22025698
Biol Psychiatry. 2017 Jan 1;81(1):78-85
pubmed: 27832841
Trends Pharmacol Sci. 2011 Mar;32(3):148-57
pubmed: 21232805
ACS Chem Biol. 2019 Aug 16;14(8):1780-1792
pubmed: 31339684
ACS Pharmacol Transl Sci. 2019 Feb 8;2(1):52-65
pubmed: 30775693
J Med Chem. 2014 Jun 12;57(11):4924-39
pubmed: 24827597
Biochim Biophys Acta Proteins Proteom. 2021 Apr;1869(4):140603
pubmed: 33421644
Nat Chem Biol. 2018 Feb;14(2):126-134
pubmed: 29227473
Front Mol Neurosci. 2012 Apr 18;5:53
pubmed: 22529776
Cell Signal. 2018 Jan;41:75-81
pubmed: 28716664
Biomedicines. 2021 Jan 22;9(2):
pubmed: 33499192
Nat Rev Drug Discov. 2017 Jan;16(1):19-34
pubmed: 27910877
Pharmacol Rev. 2019 Apr;71(2):267-315
pubmed: 30914442
Nature. 1981 Jul 30;292(5822):463-5
pubmed: 7254340
Org Lett. 2018 Jul 6;20(13):3871-3874
pubmed: 29943994
Sci Signal. 2021 Apr 06;14(677):
pubmed: 33824179
Cell Signal. 2012 Apr;24(4):951-60
pubmed: 22230688
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Curr Top Med Chem. 2016;16(29):3385-3403
pubmed: 27291902
Nature. 2018 Mar 8;555(7695):269-273
pubmed: 29466326
Science. 2010 Nov 19;330(6007):1091-5
pubmed: 21097933
J Med Chem. 2017 Apr 13;60(7):2908-2929
pubmed: 28248104
ACS Comb Sci. 2013 Jan 14;15(1):59-72
pubmed: 23240832
J Med Chem. 2018 Nov 21;61(22):9841-9878
pubmed: 29939744
Int J Clin Pract. 2015 Nov;69(11):1211-20
pubmed: 26477545
J Med Chem. 2012 Aug 23;55(16):7141-53
pubmed: 22845053
J Med Chem. 2014 Aug 28;57(16):6887-96
pubmed: 24697360
Cell. 2018 Feb 8;172(4):636-638
pubmed: 29425482
Nat Rev Drug Discov. 2004 Apr;3(4):353-9
pubmed: 15060530
J Pharmacol Exp Ther. 2007 Jan;320(1):1-13
pubmed: 16803859
Mol Pharmacol. 2014 Jul;86(1):96-105
pubmed: 24755247
Ther Adv Psychopharmacol. 2017 Jan;7(1):29-41
pubmed: 28101322
Trends Pharmacol Sci. 2018 Dec;39(12):1008-1020
pubmed: 30384981
J Med Chem. 2016 Dec 8;59(23):10601-10618
pubmed: 27805392
J Med Chem. 2015 Mar 26;58(6):2703-17
pubmed: 25734236
Nat Rev Drug Discov. 2008 Apr;7(4):339-57
pubmed: 18382464
Mol Pharmacol. 2014 Mar;85(3):492-509
pubmed: 24366668
BMC Biol. 2018 Feb 28;16(1):24
pubmed: 29486745
J Med Chem. 2019 May 9;62(9):4755-4771
pubmed: 30964661
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
J Med Chem. 2017 Jun 8;60(11):4693-4713
pubmed: 28489379
Pharmacol Ther. 2019 Aug;200:148-178
pubmed: 31075355

Auteurs

Ana Mallo-Abreu (A)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Irene Reyes-Resina (I)

Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Jhonny Azuaje (J)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Rafael Franco (R)

Faculty of Chemistry, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Aitor García-Rey (A)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Maria Majellaro (M)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Darío Miranda-Pastoriza (D)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Xerardo García-Mera (X)

Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Willem Jespers (W)

Department of Cell and Molecular Biology, Uppsala University, Uppsala SE-75124, Sweden.

Hugo Gutiérrez-de-Terán (H)

Department of Cell and Molecular Biology, Uppsala University, Uppsala SE-75124, Sweden.

Gemma Navarro (G)

Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Eddy Sotelo (E)

Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH